EC
ADAP

EcoR1 Capital’s Adaptimmune Therapeutics ADAP Stock Holding History

EcoR1 Capital’s Portfolio ADAP Stock Details ADAP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-27,404,070
Closed -$6.57M – 31
2025
Q2 		$6.57M Hold
27,404,070
– – 0.39% 29
2025
Q1 		$5.4M Hold
27,404,070
– – 0.32% 30
2024
Q4 		$14.8M Hold
27,404,070
– – 0.59% 33
2024
Q3 		$26M Hold
27,404,070
– – 0.89% 27
2024
Q2 		$26.7M Hold
27,404,070
– – 0.82% 26
2024
Q1 		$43.3M Buy
+27,404,070
New +$33.1M 1.1% 22

Other funds holding ADAP

LFCM
Long Focus Capital Management San Juan, Puerto Rico $2.28B AUM 7.31% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Jane Street
Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
EF
Empirical Finance Havertown, Pennsylvania $2.13B AUM 29.56% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.83B AUM 37.01% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $25B AUM 18.87% 1-Year Est. Return